Symptomatic Skeletal Benefits with Radium-223 Prostate Cancer Treatment

Prostate cancer patients with bone metastases are less likely to experience symptomatic skeletal events when treated with radium-223. 

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.